Submitted by Anonymous (not verified) on 3 November 2025 - 16:20
Human medicines European public assessment report (EPAR): Spexotras, trametinib, Date of authorisation: 05/01/2024, Revision: 9, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Spexotras, trametinib, Date of authorisation: 05/01/2024, Revision: 9, Status: Authorised